Characteristics of Reliever Inhaler Users and Asthma Control: A Cross-Sectional Multicenter Study in Portuguese Community Pharmacies

References

• The Global Asthma Report 2018 [Internet]. Auckland, New Zealand; 2018. Available from: www.globalasthmanetwork.org. Accessed April 6, 2021.
   Google Scholar
• Bugalho de Almeida A, Todo-bom A, Fonseca J a, Morais de Almeida M, Loureiro C, Azevedo LF, et al. INASma - Sumário do Inquérito Nacional de Controlo da Asma. DGS; 2010. Available from: https://www.dgs.pt/documentos-e-publicacoes/sumario-do-inquerito-nacional-de-controlo-da-asma-pdf.aspx.
   Google Scholar
• de Sousa JC, Santo ME, Colaço T, Almada-Lobo F, Yaphe J. Asthma in an Urban Population in Portugal: a prevalence study. BMC Public Health. 2011;11(1):347. doi:10.1186/1471-2458-11-347
   Web of Science ®Google Scholar
• Sa-Sousa A, Morais-Almeida M, Azevedo LF, et al. Prevalence of asthma in Portugal - The Portuguese National Asthma Survey. Clin Transl Allergy. 2012;2(1):1–12. doi:10.1186/2045-7022-2-15
   PubMedGoogle Scholar
• Cockcroft DW. Clinical Concerns With Inhaled β2-Agonists Adult Asthma Introduction : Background. Clin Rev Allergy Immunol. 2006;31:197–208.
   Google Scholar
• Suissa S, Blais L, Ernst P. Patterns of increasing β-agonist use and the risk of fatal or near-fatal asthma. Eur Respir J. 1994;7(9):1602–1609. doi:10.1183/09031936.94.07091602
   Web of Science ®Google Scholar
• Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992;327(26):1832–1835.
   Google Scholar
• Patel M, Pilcher J, Reddel HK, Pritchard A, Corin A, Helm C, et al. Metrics of salbutamol use as predictors of future adverse outcomes in asthma. Clin Exp Allergy. 2013;43:1144–51.
   Google Scholar
• Gerald JK, Carr TF, Wei CY, Holbrook JT, Gerald LB. Albuterol Overuse: A Marker of Psychological Distress? J Allergy Clin Immunol Pr. 2015;3(6):957–62.
   Google Scholar
• Cabrera CS, Nan C, Lindarck N, Beekman MJHI, Arnetorp S, van der Valk RJP. Sabina: global programme to evaluate prescriptions and clinical outcomes related to short-acting β2-agonist use in asthma. Eur Respir J. 2020;55(2).
   Web of Science ®Google Scholar
• Fonseca JA, Azevedo L. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy. 2010;65:1042–8.
   Google Scholar
• Global Initiative for Asthma (GINA). Pocket Guide for Asthma Management and Prevention; 2020.
   Google Scholar
• Global Strategy for Asthma Management and Prevention [Internet]; 2019. Available from: www.ginasthma.org. Accessed April 6, 2021.
   Google Scholar
• Bloom CI, Cabrera C, Arnetorp S, et al. Asthma-Related Health Outcomes Associated with Short-Acting β2-Agonist Inhaler Use: an Observational UK Study as Part of the SABINA Global Program. Adv Ther. 2020;37(10):4190–4208. doi:10.1007/s12325-020-01444-5
   PubMed Web of Science ®Google Scholar
• Janson C, Menzies-Gow A, Nan C, et al. SABINA: an Overview of Short-Acting β2-Agonist Use in Asthma in European Countries. Adv Ther. 2020;37(3):1124–1135. doi:10.1007/s12325-020-01233-0
   PubMed Web of Science ®Google Scholar
• Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short-acting β 2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J. 2020;55(4):1901872. doi:10.1183/13993003.01872-2019
   PubMed Web of Science ®Google Scholar
• Thomson NC. Reliever Inhaler Overuse, Asthma Symptoms, and Depression. J Allergy Clin Immunol Pract. 2015;3(6):963–964. (). doi:10.1016/j.jaip.2015.07.002
   Web of Science ®Google Scholar
• Eisner MD, Lieu TA, Chi F, et al. Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma. Eur Respir J. 2001;17(2):233LP– 240. doi:10.1183/09031936.01.17202330
   Web of Science ®Google Scholar
• Observatório Nacional das Doenças Respitratórias. Observatório Nacional das Doenças Respiratórias - Relatório 2017; 2017. [In Portuguese Language].
   Google Scholar
• Direção-Geral DS. Monitorização e Tratamento Para o Controlo da Asma na Criança, no Adolescente e no Adulto. 006/2018 Portugal; 2018. 1–46. [In Portuguese Language].
   Google Scholar
• Slejko JF, Ghushchyan VH, Sucher B, et al. Asthma control in the United States, 2008–2010: indicators of poor asthma control. J Allergy Clin Immunol. 2014;133(6):1579–1587. doi:10.1016/j.jaci.2013.10.028
   PubMed Web of Science ®Google Scholar
• Francis MLL, Andrews R, Buckingham R, Evans H, Francis C, Houston R, et al. Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry report. Royal College of Physicians. London; 2014.
   Google Scholar
• Worth A, Hammersley V, Knibb R, et al. Patient-reported outcome measures for asthma: a systematic review. Npj Prim Care Respir Med. 2014;24. doi:10.1038/npjpcrm.2014.20
   Web of Science ®Google Scholar
• Pavord ID, Mathieson N, Scowcroft A, Pedersini R, Isherwood G, Price D. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: A cross-sectional analysis. npj Prim Care Respir Med. 2017;27(17).
   Google Scholar
• Yaghoubi M, Adibi A, Safari A, Fitzgerald JM, Sadatsafavi M. The Projected Economic and Health Burden of Uncontrolled Asthma in the United States. Am J Respir Crit Care Med. 2019;200(9):1102–12.
   Google Scholar
• Sá-Sousa A, Amaral R, Morais-Almeida M, et al. Asthma control in the Portuguese National Asthma Survey. Rev Port Pneumol. 2015;21(4):209–213.
   Web of Science ®Google Scholar
• Chatterjee AB. Reliability in reporting asthma history and age at asthma onset. J Asthma. 2015;51(9):956–63.
   Google Scholar
• Hafferty JD, Campbell AI, Navrady LB, et al. Self-reported medication use validated through record linkage to national prescribing data. J Clin Epidemiol. 2018;94:132–142. doi:10.1016/j.jclinepi.2017.10.013.
   Web of Science ®Google Scholar